OphthoAcademy
Phakic IOLs & ICL
Overview
A phakic intraocular lens is implanted into an eye that keeps its own natural crystalline lens. It adds refractive power in front of or behind the iris rather than replacing the lens, the way a cataract extraction or refractive lens exchange does. Accommodation is fully preserved, which is why the category appeals to younger, still-accommodating patients whose refractive error is too high, or whose cornea is too thin, for LASIK or PRK to correct safely.
The core indication is high myopia or hyperopia in someone who is a poor candidate for corneal refractive surgery. Usually that means a cornea too thin to remove enough tissue safely, though irregular corneas and refractive errors beyond LASIK's effective range point the same direction.
Phakic IOL Classification
Phakic IOLs are grouped by where in the eye they sit. Placement, in turn, largely dictates the risk profile.
Posterior Chamber Phakic IOLs
Posterior chamber phakic IOLs sit in the ciliary sulcus, behind the iris and in front of the natural crystalline lens. The Implantable Collamer Lens (ICL) is the dominant modern example. Because these lenses don't contact the corneal endothelium or the iridocorneal angle directly, they carry a more favorable long-term safety profile than the anterior-chamber designs below and are now the most widely used phakic IOL category.
Angle-Supported Phakic IOLs
Angle-supported designs sit in the anterior chamber, with their haptics resting directly in the iridocorneal (anterior chamber) angle. Chronic haptic contact with the angle was associated with significant endothelial cell loss, chronic low-grade inflammation, and pupil ovalization. Early angle-supported lenses have largely been abandoned for that reason, and most surgeons now favor iris-fixated or posterior chamber designs instead.
Iris-Fixated Phakic IOLs
Iris-fixated ("iris-claw") lenses, such as the Artisan or Verisyse, also sit in the anterior chamber. Rather than resting in the angle, though, they are enclavated to the midperipheral iris: two haptic claws pinch and hold a small fold of iris stroma, suspending the lens without contacting the angle or the sulcus.
Candidacy Criteria
A phakic IOL sits permanently in an eye that keeps its own crystalline lens and endothelium, so candidacy comes down to how much anatomic margin the eye has to tolerate a foreign object indefinitely:
- Anterior chamber depth of at least approximately 3.0 mm (measured from the corneal endothelium to the anterior lens surface) is generally required, to keep adequate clearance from both the cornea and the natural lens and reduce the risk of endothelial touch or angle-closure complications.
- Endothelial cell density of roughly 2000 cells/mm² or more is typically required, since phakic IOLs carry a lifelong risk of accelerated endothelial cell loss and the cornea needs enough reserve to tolerate it.
- Refractive stability for at least one year prior to surgery is required. An unstable refraction risks a poor postoperative outcome and progressive residual refractive error, and is considered an absolute contraindication until stability is documented.
The Implantable Collamer Lens (ICL)
The Implantable Collamer Lens, marketed as the Visian ICL, is the phakic IOL most commonly used today for correcting high myopia. It is made of a collagen copolymer material and placed as a posterior chamber phakic IOL in the sulcus. FDA approved and commonly used across a wide myopic range, up to roughly -20 diopters, it fits the very high myopes who fall outside the effective range of corneal laser correction.
Proper sizing is central to a good outcome and is guided by white-to-white corneal diameter, often combined with sulcus-to-sulcus measurement. An undersized lens vaults too little and can rub against the natural lens; an oversized one vaults excessively and crowds the angle. The target postoperative vault, the distance between the back of the ICL and the front of the natural crystalline lens, is approximately 500 micrometers, roughly equal to central corneal thickness. That figure balances adequate clearance from the natural lens against excessive angle crowding.
Modern ICL models incorporate a small central hole, the KS-AquaPort, engineered to let aqueous humor circulate freely through the lens itself. This removes the need for a separate preoperative or intraoperative peripheral iridotomy that older, solid-optic ICL designs required to prevent pupillary block.
A toric version of the ICL (TICL) corrects astigmatism in addition to the spherical refractive error, built from a cylindrical correction ground into the optic along a specific meridian. That meridian has to land on the intended axis at implantation, because even a few degrees of rotational misalignment away from it erodes the astigmatic correction rather than just leaving it unchanged. Surgeons mark the eye preoperatively and verify lens position intraoperatively for exactly this reason. A toric ICL that has rotated postoperatively, with a well-formed vault and no cataract or pupillary block, typically needs surgical repositioning rather than observation.
Complications
Each phakic IOL family has a complication that tracks directly from its anatomic placement:
- Pupillary block / secondary angle closure. A shallow anterior chamber, or an oversized ICL that vaults excessively, narrows the space for aqueous flow and can precipitate an acute IOP rise from pupillary block, sometimes severe enough to require lens exchange for an oversized ICL.
- Endothelial cell loss. Any anterior-chamber phakic IOL, and to a lesser degree an ICL that vaults too little, risks progressive, insidious endothelial cell loss over years, since the endothelium doesn't regenerate.
- Iris atrophy and pupil ovalization. Specific to iris-fixated (iris-claw) lenses: the chronic mechanical stress of the haptic claws pinching the same fold of iris tissue over years causes progressive iris atrophy and pupil ovalization.
- Chronic inflammation and endothelial loss from sustained haptic contact with the angle, the reason angle-supported designs fell out of favor.
A peripheral iridotomy was traditionally performed alongside angle-supported or iris-fixated phakic IOL implantation to prevent pupillary block. Because the lens sits in front of the natural lens, it can obstruct aqueous flow through the pupil; the iridotomy creates an alternate outflow route. Modern AquaPort-equipped ICLs achieve the same protection without a separate iridotomy.
Don't assume every ICL needs a preoperative iridotomy just because older anterior-chamber phakic IOL teaching does. The AquaPort central hole in current ICL models already provides the aqueous flow pathway a solid-optic lens would otherwise need an iridotomy to create.
Postoperative Monitoring
Corneal endothelial cell density requires the most vigilant long-term monitoring after any phakic IOL implantation. Endothelial cells don't regenerate, so loss accumulates silently over years before becoming symptomatic and the damage, once present, is irreversible. Serial specular microscopy catches early decompensation before it progresses.
- Posterior chamber (ICL) = sulcus, behind iris; angle-supported = anterior chamber angle; iris-fixated = enclavated to midperipheral iris.
- Angle-supported phakic IOLs are largely historical: abandoned for endothelial loss, inflammation, and pupil ovalization.
- ICL candidacy: anterior chamber depth ≥ ~3.0 mm, endothelial cell density ≥ ~2000 cells/mm², ≥1 year refractive stability.
- Target ICL vault ≈ 500 µm; AquaPort central hole removes the need for a separate iridotomy.
- Iris-claw lens complication to know cold: progressive iris atrophy/ovalization from chronic haptic enclavation.
Related Topics
Continue exploring Cataract & Refractive Surgery:
Test yourself on Phakic IOLs & ICL
OphthoAcademy has real practice questions on this exact subtopic, with spaced repetition to help it stick.
Try it in your browser